The HRSA HIV/AIDS Bureau's Infographic summarizes data on clients served and health outcomes among people getting HIV-related medical care from the Ryan White HIV/AIDS Program
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.